Successful treatment of graft-vs-host disease after a second liver transplant.
Aziz
H
H
Liver Transplantation Unit, Hospital Argerich, Buenos Aires, Argentina. aziz@sat.org.ar
Trigo
P
P
Lendoire
J
J
Bianco
G
G
Saúl
J
J
Braslavsky
G
G
Kien
M
M
Zylberman
M
M
Cueto
G
G
Imventarza
O
O
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000473:pathology / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D009503:Neutropenia / Q000209:etiology / Q000628:therapy; D012086:Reoperation; D013927:Thrombosis
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016179:Granulocyte Colony-Stimulating Factor